DOC Generici (ICG)
Entry
2019
Hold
3yr
Exit
2022
Who owns DOC Generici (ICG)?
DOC Generici (ICG) is an Italian Pharma company, currently owned by TPG Europe since 2022. It changed hands in 2022, when ICG sold.
Hand-verified · updated 2026-09-30
Open JSON · CC-BYMost recent investor
ICGICG Europe Fund VII · 2018 · Mezzanine
2 ownership periods · full history below
Key facts
HQItaly
SectorPharma
StatusAcquired
Ownership history
2 ownership periods
Active
TPG EuropeActive
2022 · present(4yr) · TPG Europe Portfolio · Buyout
More from ICG Europe Fund VII
Other portfolio companies in the same fund.
More PE-backed in Pharma
Comparable pharma deals from other GPs.
Questions
Who owns DOC Generici (ICG)?
DOC Generici (ICG) is currently owned by TPG Europe, through ICG Europe Fund VII, since 2022.
When did TPG Europe acquire DOC Generici (ICG)?
TPG Europe acquired DOC Generici (ICG) in 2022.
Who did DOC Generici (ICG) sell to?
ICG sold DOC Generici (ICG) to TPG in 2022 (Secondary).
Who has owned DOC Generici (ICG) over time?
DOC Generici (ICG) has been through 2 private-equity ownership periods: ICG · via ICG Europe Fund VII · 2019–2022 · sold to TPG · (Secondary); TPG Europe · since 2022.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue